Skip to main content

Table 1 Mean and median serum hCT concentrations for the different patient groups

From: Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a cautionary note

Patient group Number Median Mean Standard deviation
Group 1: Hashimoto’s thyroiditis 122 4.120 5.368 5.0051
Group 2: nodular goitre and PPI therapy 73 6.060 6.341 3.9486
Group 3: nodular goitre without
PPI therapy
118 5.740 6.212 4.0923
Group 4: normal thyroid and PPI therapy 59 6.100 8.672 9.4468
Group 5: normal thyroid without PPI therapy 121 5.200 6.491 6.2806
Total 493 5.350 6.385 5.7845